S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
France backs Italy in vaccine ban as EU defends mechanism
pixel
3 Tech Stocks on Sale to Buy Carefully
Analysts are Calling These 3 Pullbacks Buy Opportunities
China sets growth target 'over 6%,' tightening HK control
SEC suing AT&T for telling analysts nonpublic information
Tech rebound pulls stocks out of a slump and to weekly gain
US stocks turn mixed as bond yields continue their climb
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
France backs Italy in vaccine ban as EU defends mechanism
pixel
3 Tech Stocks on Sale to Buy Carefully
Analysts are Calling These 3 Pullbacks Buy Opportunities
China sets growth target 'over 6%,' tightening HK control
SEC suing AT&T for telling analysts nonpublic information
Tech rebound pulls stocks out of a slump and to weekly gain
US stocks turn mixed as bond yields continue their climb
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
France backs Italy in vaccine ban as EU defends mechanism
pixel
3 Tech Stocks on Sale to Buy Carefully
Analysts are Calling These 3 Pullbacks Buy Opportunities
China sets growth target 'over 6%,' tightening HK control
SEC suing AT&T for telling analysts nonpublic information
Tech rebound pulls stocks out of a slump and to weekly gain
US stocks turn mixed as bond yields continue their climb
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
France backs Italy in vaccine ban as EU defends mechanism
pixel
3 Tech Stocks on Sale to Buy Carefully
Analysts are Calling These 3 Pullbacks Buy Opportunities
China sets growth target 'over 6%,' tightening HK control
SEC suing AT&T for telling analysts nonpublic information
Tech rebound pulls stocks out of a slump and to weekly gain
US stocks turn mixed as bond yields continue their climb
Log in
NASDAQ:JAN

JanOne Stock Forecast, Price & News

$7.77
+0.76 (+10.84 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.72
Now: $7.77▼
$7.89
50-Day Range
$5.23
MA: $8.00▼
$12.99
52-Week Range
$2.01
Now: $7.77▼
$31.83
Volume489,217 shs
Average Volume926,683 shs
Market Capitalization$18.66 million
P/E RatioN/A
Dividend YieldN/A
Beta2.24
JanOne Inc. develops treatments for conditions that cause severe pain. The company, through its non-addictive pain-relieving drugs, focuses on reduction for need of opioid prescriptions to treat disease associated pain that can lead to opioid abuse. Its lead candidate JAN101 provides slow-release formulation of sodium nitrite therapeutic for treatment of peripheral artery disease (PAD). The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
JanOne logo

Headlines

JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million
February 25, 2021 |  finance.yahoo.com
JanOne Announces Closing of $6.0 Million Common Stock Offering
February 2, 2021 |  finance.yahoo.com
Why Is It Moving? Analyzing The Downward Movement in JanOne's Stock Today
January 29, 2021 |  msn.com
Why Is It Moving? Looking At JanOne's Price Action Today
January 28, 2021 |  msn.com
JanOne Inc
December 31, 2020 |  bloomberg.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Home furniture, furnishings & equipment stores
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:JAN
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.janone.com
Phone702 997 5968
Employees199
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio0.41
Quick Ratio0.36

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$35.10 million
Price / Sales0.53
Cash FlowN/A
Price / Cash FlowN/A
Book Value$5.39 per share
Price / Book1.44

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-11,960,000.00
Net Margins-33.60%
Return on Equity-161.07%
Return on Assets-45.22%

Miscellaneous

Outstanding Shares2,401,000
Market Cap$18.66 million
Next Earnings Date3/8/2021 (Estimated)
OptionableNot Optionable

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Medical Sector

1959th out of 1,972 stocks

Home Furniture, Furnishings & Equipment Stores Industry

9th out of 9 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$7.77
+0.76 (+10.84 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive JAN News and Ratings via Email

Sign-up to receive the latest news and ratings for JAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











JanOne (NASDAQ:JAN) Frequently Asked Questions

What stocks does MarketBeat like better than JanOne?

Wall Street analysts have given JanOne a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but JanOne wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting JanOne?

JanOne saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 65,400 shares, an increase of 58.4% from the January 28th total of 41,300 shares. Based on an average daily trading volume, of 669,600 shares, the short-interest ratio is currently 0.1 days. Approximately 4.7% of the shares of the stock are short sold.
View JanOne's Short Interest.

When is JanOne's next earnings date?

JanOne is scheduled to release its next quarterly earnings announcement on Monday, March 8th 2021.
View our earnings forecast for JanOne.

Who are JanOne's key executives?

JanOne's management team includes the following people:
  • Mr. Tony Isaac, Pres, CEO & Director (Age 67, Pay $571.43k)
  • Mr. Eric Bolling, Pres (Age 59, Pay $148.08k)
  • Mr. Virland A. Johnson CPA, Chief Financial Officer (Age 61, Pay $125.27k)
  • Dr. Tony Giordano, Chief Scientific Officer
  • Ms. Cyndy L. Janzig, Director of HR
  • Dr. Amol Soin, Chief Medical Officer
  • Dr. Douglas Flanagan, Chief Formulation Advisor
  • Mr. Michael J. Stein, Corp. Sec. (Age 48)

Who are some of JanOne's key competitors?

Some companies that are related to JanOne include Williams-Sonoma (WSM), Bed Bath & Beyond (BBBY), At Home Group (HOME), The Container Store Group (TCS), Tile Shop (TTSH), 1847 Goedeker (GOED) and Pier 1 Imports (PIRRQ).
View all of JAN's competitors.

What is JanOne's stock symbol?

JanOne trades on the NASDAQ under the ticker symbol "JAN."

How do I buy shares of JanOne?

Shares of JAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is JanOne's stock price today?

One share of JAN stock can currently be purchased for approximately $7.77.

How much money does JanOne make?

JanOne has a market capitalization of $18.66 million and generates $35.10 million in revenue each year.

How many employees does JanOne have?

JanOne employs 199 workers across the globe.

What is JanOne's official website?

The official website for JanOne is www.janone.com.

Where are JanOne's headquarters?

JanOne is headquartered at 325 E. Warm Springs Road Suite 102, Las Vegas NV, 89119.

How can I contact JanOne?

JanOne's mailing address is 325 E. Warm Springs Road Suite 102, Las Vegas NV, 89119. The company can be reached via phone at 702 997 5968 or via email at [email protected]


This page was last updated on 3/6/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.